Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 191 - 200 of 225

Selected Filters:
15 September 2020

Plan 4 PrEP: Étape 5: Évaluation de l’état de Préparation des Installations

Cette boîte à outils a été développée et utilisée par le Consortium OPTIONS pour soutenir la planification de l'introduction de la PrEP orale pour la prévention du VIH au Kenya, au Zimbabwe et en Afrique du Sud. Cette boîte à outils est conçue pour aider les utilisateurs d'autres pays à planifier l'introduction de la PrEP…

Community/Advocacy, Demand Creation/Marketing, Financing & Costing, Monitoring & Evaluation, Service Delivery, Supply Chain Management

Document
24 July 2020

Guidance for the Use of Pre-exposure Prophylaxis (PrEP) for the Prevention of HIV Acquisition in British Columbia

These guidelines were developed by the British Columbia Centre for Excellence in HIV/AIDS and focus on the provision of PrEP as a part of a comprehensive approach to combination prevention, drawing on implementation and research evidence and WHO recommendations.

Normative Guidance/Policies

Document
23 June 2020

Listening to Young Women in Kenya and South Africa to Inform Multipurpose “2-in-1” Products for HIV and Pregnancy Prevention

The Tablets, Ring, Injections as Options study, or TRIO, was conducted with young women aged 18 to 30 in Kisumu, Kenya and Soshanguve, South Africa between 2015 and 2017. The study examined young women's perspectives on future MPT in a clinical study of three placebo MPT products.

Research

Document
23 June 2020

What End-Users Think About HIV Prevention Products and Multipurpose Prevention Technologies (MPTs)

The Tablets, Ring, Injections as Options study, or TRIO, was conducted with young women aged 18 to 30 in Kisumu, Kenya and Soshanguve, South Africa between 2015 and 2017. The study examined young women's perspectives on future MPT in a clinical study of three placebo MPT products. TRIO identified anticipated enablers and barriers to adoption…

Research

Document
26 May 2020

Oral PrEP Youth Dialogues South Africa

What AGYW really think about PrEP, HIV services and how we talk to them!

Demand Creation/Marketing, Research

Document
12 May 2020

We Are The Generation

The OPTIONS Consortium supported the National Department of Health, South Africa, with the development of information, education and communication (IEC) materials for the launch of oral PrEP for female sex workers, men who have sex with men and university students. These materials were designed with inputs from local South African sex worker, MSM and youth…

Demand Creation/Marketing

2 April 2020

Dapivirine Ring Compendium of End-User Insights

A summary of existing end-user research findings related to the ring and gaps remaining, all in a digestible compendium.

Research

Document
26 March 2020

Measuring Social Harms in Research and Programs on Women-Initiated HIV Prevention Methods

This brief summarizes how five HIV prevention trials defined and measured social harms and makes recommendations for future research and programs.

Monitoring & Evaluation, Research

Document
7 January 2020

Private and Public Introduction Stakeholder Consultations

This slide deck shares key stakeholder insights on potential introduction pathways and related considerations for the ring via both the private and public sector in Kenya, South Africa and Zimbabwe. This tool is intended to be used by implementers and researchers as they consider how to incorporate the dapivirine vaginal ring into existing and future…

Service Delivery

Document
7 January 2020

Market Authorization 101

This slide deck outlines a potential path of market authorization for the dapivirine vaginal ring. It clarifies the necessary regulatory, normative guidance, and policy steps at the global and country levels that would be needed to support ring introduction. This Market Authorization 101 deck is intended to illustrate the ring pathway to market and assist…

Normative Guidance/Policies

Document